Literature DB >> 29768274

Reliability of a New Symptom Score in a Titrated Quantitative Conjunctival Provocation Test Supported by an Objective Photodocumentation.

Oliver Pfaar1,2, Dan Philipp Claßen1,2, Anatoli Astvatsatourov3,4, Ludger Klimek2, Ralph Mösges4.   

Abstract

BACKGROUND: Allergen provocation tests are useful methods for proving the clinical relevance of an allergen-specific sensitization. Among these methods, the conjunctival provocation test (CPT) represents an easy-to-use tool. However, its readout parameters have not yet been internationally standardized or validated. Photodocumentation has been shown as a good option for objectifying a CPT reaction, supporting the local investigator assessment. Based on test-retest reliability of the score and an objective digital photoanalysis of the conjunctival redness, this study aimed to prove the reproducibility of a new CPT scoring system for use in clinical trials (ClinicalTrials.gov identifier: NCT02690740).
METHODS: A titrated quantitative CPT was conducted outside of the pollen season in a final cohort of 23 adult patients with birch or grass pollen-induced allergic rhinoconjunctivitis. Conjunctival symptoms were analyzed using a standardized symptom score. Conjunctival redness was also evaluated by an external observer and correlated with a digital photoanalysis using MATLAB software.
RESULTS: A test-retest correlation of 0.6 (p < 0.01) was found for the symptom score results. Likewise, a correlation of 0.65 (p < 0.01) was observed in the digital photoanalysis. The total symptom score showed a decrease in the mean value of 0.48 score points in the retest.
CONCLUSIONS: This study reveals both a valuable test-retest correlation of the proposed score as well as a good correlation of eye redness with the (objective) photodocumentation. Based on our results, we can recommend the use of this scoring system as a valuable clinical protocol for future clinical trials.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Allergic rhinoconjunctivitis; Clinical score; Conjunctival provocation test; Photodocumentation; Titrated quantitative conjunctival provocation test

Mesh:

Year:  2018        PMID: 29768274     DOI: 10.1159/000487884

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  2 in total

1.  Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing.

Authors:  S Zielen; P Kuna; W Aberer; S Lassmann; O Pfaar; L Klimek; A Wade; K Kluehr; J Raab; D Wessiepe; D Lee; M F Kramer; K Gunawardena; T Higenbottam; M D Heath; M A Skinner; P J de Kam
Journal:  World Allergy Organ J       Date:  2019-10-25       Impact factor: 4.084

2.  Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy.

Authors:  M Worm; T Higenbottam; O Pfaar; R Mösges; W Aberer; K Gunawardena; D Wessiepe; D Lee; M F Kramer; M Skinner; B Lees; S Zielen
Journal:  Allergy       Date:  2018-06-19       Impact factor: 13.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.